Unveiling the power of Treg.Sig: a novel machine-learning derived signature for predicting ICI response in melanoma
BackgroundAlthough immune checkpoint inhibitor (ICI) represents a significant breakthrough in cancer immunotherapy, only a few patients benefit from it. Given the critical role of Treg cells in ICI treatment resistance, we explored a Treg-associated si…